Search results for "ffpe challenges"

Hear from experts on how active customer collaboration helps to develop a clinical instrument designed to enable efficient, accurate and timely results crucial to enhance patient care

bioMérieux conducts in-depth analyses of its molecular tests on emerging variants of concern

How LC-MS/MS could improve the speed, selectivity, and cost-efficiency of therapeutic oligonucleotide quantification

Prof. Roberto Torresi shares his current research aimed at enhancing the capacity, safety, and sustainability of energy storage systems

Discover how immunohistochemistry is supporting the identification of molecular subtypes of breast cancer

Dr Derek C. Lenz from Mettler-Toledo answers all your webinar questions about UV/Vis applications in life sciences

Explore topics from optical spectroscopy, x-ray diffraction, high-resolution ion mobility mass spectrometry, CAR-T cell sensitivity and persistence

Discover how a universal solution for non-specific adsorption could improve the sensitivity and reproducibility of your analyses while saving time and effort

Explore how a partnership between a lead researcher in sexual health and a molecular diagnostics innovator helped to overcome the therapeutic hurdles that come with antibiotic resistance

For automated purification of total RNA, or total RNA with miRNA, from tissues or cells

Sequence hotspots in EGFR, KRAS, NRAS and BRAF

World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance

In this SelectScience special feature, learn about the latest in next-generation sequencing (NGS) technologies and techniques

Elevating respiratory research through precise inhalation technology

Discover insights on topics from lab automation and drug development to clinical LC-MS/MS and point-of-care testing

Antibody expert, Dr. Chelcie Eller, shares how to achieve reliable and reproducible high-throughput drug and biomarker screening

Global leaders convene to map new paths to diagnose and treat Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases that afflict one in six people